IP Verse

Propylene Glycol Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices - EP3300721

PATENT ANALYSIS

Patent Details

Grant Date
Mar 6, 2019
Company
NOVO NORDISK A/S
Oppositions

DR. REDDY'S LABORATORIES LIMITED

GALENICUM HEALTH S.L.U.

GENERICS (U.K.) LIMITED

HOFFMANN EITLE

TEVA PHARMACEUTICAL INDUSTRIES LTD

More patents of Novo Nordisk A/S

EP3488857

EP3542790

EP3746111

Want to monitor this patent?

Feel free to send us a message here and we will get back to you